Results 131 to 140 of about 7,241 (205)

Urinary betaine/creatinine ratio enhances diagnostic accuracy of PLA2R-Ab in idiopathic membranous nephropathy. [PDF]

BMC Nephrol
Wang J, Shao L, Lin B, Xi Y, Jiang Y, Qin X.   +5 more
europepmc   +1 more source

Methylprednisolone plus Chlorambucil as Compared with Methylprednisolone alone for the Treatment of Idiopathic Membranous Nephropathy.

, 1992
CESANA, Bruno Mario, Ponticelli C, the Italian Idiopathic Membranous Nephropathy Treatment Study Group, Zucchelli P, Passerini P   +4 more
core  

Multi-omics insights of immune cells in the risk and prognosis of idiopathic membranous nephropathy. [PDF]

Commun Biol
Song X, Zhu W, Li Y, Li Z, Cao W, Lu J, Pan W, Wei J, Li M.   +8 more
europepmc   +1 more source

First-line and Second-line Therapy of Zuberitamab in Idiopathic Membranous Nephropathy: A Single-center Retrospective Study. [PDF]

Kidney Med
Wang L, Yang M, Yan L, Shao F.
europepmc   +1 more source

Clinical efficacy and safety of tripterygium wilfordii glycosides in the treatment of idiopathic membranous nephropathy: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Liu Y, Lu K.
europepmc   +1 more source

SPP1 as a biomarker for idiopathic membranous nephropathy progression and its regulatory role in inflammation and fibrosis. [PDF]

Front Immunol
Pang S, Zhou R, Liu Z, Xie B, Liu F, Feng B, Chen X, Ruan L, Chen H, Xie Y, Tan Q, Zhao B, Li S, Xue C, Yang R, Li W.   +15 more
europepmc   +1 more source

Exploring the mechanism of Kemofang in treating idiopathic membranous nephropathy based on LC-MS/MS combined with network pharmacology, molecular docking, and molecular dynamics simulation. [PDF]

Sci Rep
Yu H, Li F, Yu H, Jiang X, Ma S, Zhang S.   +5 more
europepmc   +1 more source

Development of a prognostic model for in-hospital mortality in idiopathic membranous nephropathy patients with Pneumocystis jirovecii pneumonia based on persistent lymphopenia. [PDF]

BMC Infect Dis
Wang Y, Liu K, Huang C, Fu M, Lou L, Zhou Y, Li S.   +6 more
europepmc   +1 more source

Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study. [PDF]

Front Immunol
Huang J, Yang Y, Wang Y, Jiang S, Zhang Y, Zhao S, Wang S, Chen B, Liu G.   +8 more
europepmc   +1 more source

The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study. [PDF]

Sci Rep
Li X, Liu Y, Zhu X, Jin H, Zhang X, Wang L, Cui Y, Xu F, Wang Y, Song Y, Cui W.   +10 more
europepmc   +1 more source